Read More Analyst Ratings News Price Target DA Davidson Maintains Neutral on Redfin, Raises Price Target to $7.5 By Benzinga Newsdesk March 9, 5:30 AM DA Davidson analyst Tom White maintains Redfin (NASDAQ:RDFN) with a Neutral and raises the price target from $5.5 to $7.5. RDFN
Read More Biotech Contracts General Health Care Movers News Penny Stocks Trading Ideas Medigus’ Polyrizon Inks Agreement To Develop Therapies For Traumatic Spinal Cord Injuries By Vandana Singh July 18, 8:51 AM Polyrizon Ltd, in which Medigus Ltd (NASDAQ:MDGS) owns a 37.03% stake, signed a binding Collaboration Agreement with NurExone Biologic Inc for therapies for traumatic spinal… MDGS
Read More Analyst Color Analyst Ratings Earnings Movers News Reiteration Top Stories Trading Ideas Asana’s Stock Tanks After Q2: 5 Analysts Look At What Happened, Outlook By Priya Nigam September 6, 12:47 PM Shares of Asana Inc (NYSE: ASAN) plummeted in trading on Wednesday, after recording losses with other stocks in the pre-market. ASAN
Read More Analyst Color Analyst Ratings News Tech Top Stories Apple Has Canceled The Next iPhone SE, Top Analyst Says — And This Company Stands To Benefit Big By Ananya Gairola January 9, 12:33 AM Apple Inc. (NASDAQ: AAPL) has instructed suppliers about canceling the 2024 iPhone SE 4, according to a top analyst of the Cupertino-based tech giant. AAPL